Gut bugs’ can drive prostate cancer growth and treatment resistance
Common gut bacteria can fuel the growth of prostate cancers and allow them to evade…
Browsing: Prostate Cancer
Study examines information and communication needs of men with prostate cancer
In a recent study published in the European Journal of Cancer Care, investigators interviewed men affected…
How a new imaging tool helps to better stage men with prostate cancer
Prostate-specific membrane antigen, or PSMA, targeted PET imaging for prostate cancer has been a breakthrough…
ESMO 2021: STAMPEDE Prostate Cancer Trial
Highlights on MFS analysis from combined treatments in high-risk advanced prostate cancer
ESMO 2021: New combination of old drugs improves survival in patients with prostate cancer
A novel combination of well-known drugs prolongs survival in patients with hormone/castration-sensitive prostate cancer, according…
ESMO 2021: Possible changes in the standard of care for metastatic and non-metastatic prostate cancer
Addition of abiraterone acetate plus prednisone shows clear survival improvements in castration-sensitive prostate cancer Two…
Genomic comparison of prostate cancer cells eradicated by and resistant to treatment allows researchers to identify targets for enhanced therapy
A study published in Cancer Research introduces Differential Subclone Eradication and Resistance Analysis (DSER), an approach developed…
ESMO 2021: ARCHES study finds enzalutamide reduced risk of death by 34% in men with metastatic hormone-sensitive prostate cancer
Results from the ARCHES study, presented at the European Society for Medical Oncology (ESMO) Congress 2021,…
Australian trial first to demonstrate preserved quality of life in curative radiation therapy for early recurrent prostate cancer
Icon Group have announced the interim results of a first-of-its-kind study, PINPOINT, which shows that…
Shorter course of radiotherapy safely delivers treatment for prostate cancer
Advanced radiotherapy technology can safely deliver curative treatment for prostate cancer patients in as few…